Imaging procedures such as 1-(2-[18F]FLUOROETHYL)-L-Tryptophan PET/CT in patients with
cancers may help doctors assess a patient's response to treatment and help plan the best
treatment in the future. The purpose is to see if there can be a better differentiation of
tumor and non-tumor tissue where the tumor tissue has a higher uptake of Tryptophan.